The University Of Georgia
Program name: Pharmacy Management Program
Study Level: Graduate
Program leader: Vasadze Otar
Turdziladze Tinatin
Study language: Georgian, with some English components
Qualification: Master of Pharmacy Management
Program capacity: 120
Program permission: Enrollment of students in the second level of higher education (master's program) is carried out in accordance with the results of the Unified Master's exams or the order of the Minister of Education and Science of Georgia №224 / N (December 29, 2011), as a result of passing the internal university exam (English language level B2) and passing the oral interview in the specialty, on the basis of passing the administrative registration and the order of the President. Confirmation of English language proficiency is possible by presenting an international language certificate (TOEFL (87), IELTS (6.5) or other relevant B2 level score) or by exceeding the 70% threshold of the university's institutional test.
Program goals:

Train pharmacy managers whose professional activities will help the healthcare system to function effectively, improving the health of the population by increasing the availability of safe, effective and quality pharmaceutical products. Will be able to research, evaluate and administer external and internal challenges to the validity of the state model of pharmaceutical management, external and internal challenges to the pharmaceutical system / organization. The graduate of the program, Master of Pharmacy Management, will be able to carry out high-level managerial activities in organizations of state, international and private legal form in such segments of pharmaceutical activities as: State administration of pharmaceutical products, pharmaceutical production, distribution, logistics quality control, import and export promotion, administration of clinical trials and pharmacovigilance, activities of insurance companies in the field of pharmacoeconomics. He will be able to continue his scientific research activities and study at the post-doctoral level.

Methods for Attaining Learning Outcomes:
  • Lecture-seminar;
  • Explanation method;
  • Demonstration method ;
  • Using of audio-video learning material;
  • Situational exercises;
  • Posing and solving the problems;
  • Discussion;
  • Critical analysis;
  • Projects;
  • Exercises oriented on solving of the problems;
  • Case study;
  • Literature review;
  • Searching the files in electronic format or library;
  • Writing topics;
  • Presentation;
  • Verbal method;
  • Small volume research;
  • Written work method;
  • Teamwork skills;
  • Visual lectures;
  • Induction-deduction, analysis and synthesis;
  • Debate;
  • Practical work;
Learning outcomes:
Knowledge and understanding
  • Know the Global, International and Public Health Policy, Health Systems Management, Management Economics, Pharmaceutical Economics and Pharmaceutical Policy, Pharmaceutical Oversight, Pharmaceutical Quality Management, Drug Authorization, Clinical Research Business Administration, Pharmaceutical Supervision and Pharmaceuticals;

    Know the management, incl. features of the management process of the organization, the universal functions of pharmaceutical management, teamwork and leadership, decision making, decision making and implementation stages, which lead to the development of new ideas or proposals for the management of the system, each segment of the field of pharmaceutical management and statistical processing characteristics;

    Have s systematic knowledge of pharmaceutical quality management system, in particular, will understand GMP API (Good Manufacturing Practice of Active Pharmaceutical Product), GMP MP (Good Manufacturing Practice of Medicinal Product), GDP API (Good Distribution Practice of Active Pharmaceutical Product), GDP MP (Good Distribution Practice of Medicinal Product) GDP Exipien (Good Distribution Practice of Excipient), GSP (Good Storage Practice), quality Correction And Process Assurance (CAPA) system, through which it will understand ways to solve drug safety, quality, efficacy problems at the production, distribution and logistics stages;

    Know the correct clinical practice (GCP) and ethical principles of research (well-being of research subjects, etc.);

    Understand specific pricing strategies  (including cartel transactions, price leadership, discrimination, unlimited pricing).

  • Skills
  • Formulate and control the organization of healthcare, mission and goals of pharmaceuticals, strategic and current plans (including quality management), marketing of pharmaceutical products, organization of work and human resources, management and control of work under the plan;

    Plan, implement and audit the systemic activities of multidisciplinary quality assurance and correction (CAPA) at the stage of distribution of the pharmaceutical product, as well as have an ability of strategic planning of the projected side effects of the drugs consumed, clinical research administration, business plan design, strategic planning;

    Solve complex problems arising during the administration process (well-being of the clinical research subject, compensation, violation of standard information procedures, etc.) with new approaches, processing of research results with the latest statistical methods and approaches;

    Formulate a reasoned opinion on the systematic level of innovative information synthesis and critical analysis of data on the results of complex information and computational covariance and correlation in pharmaceutical systems, pharmaceutical structures, pharmaceutical markets and research;

    Process statistically the data on the innovative synthesis of complex information and computed covariance and correlation results in pharmaceutical structures, pharmaceutical market and research, form a reasoned opinion about their critical analysis at the systemic level of health;

    Evaluate the system based on a critical analysis of processes provided by the GMP MP (Good Manufacturing Practice of Medicinal Product) and GMP API /(Good Manufacturing Practice of Active Pharmaceutical Product);

    Formulate a final assessment based on a critical analysis of complex modular information (safety, quality, efficacy, legality, ethical aspects of the pharmaceutical industry);

    Make reasoned decisions based on the validity of regulatory models / instruments and the rationality of pharmacotherapy based on a critical analysis of the latest data on pharmaceutical policy and pharmacoeconomics.

  • Responsibility and autonomy
  • Strategically plan and study Healthcare, incl. pharmaceutical management, supervision, drug authorization, research, quality system as a dynamically developing field, the need for further in-depth study, and independent study of individual issues (including statistical-mathematical);

    Assess the social corporate responsibility of the pharmaceutical entity to the public, as well as promote the principles of managerial, medical, pharmaceutical ethics in the provision of health services;

    Assess the advantages of standardized management over the principles of directive management and to promote its establishment, as well as to assess the attitudes of self and health professionals in the ethics of drug use, research and pharmacy in general.;

  • Date of approval: 02-26-2016
    Approval protocol number: 07.16
    Date of program update:
    Update protocol number: 19/16
    Program details:

    In the field of pharmaceutical management, the student performs research work, writes abstracts, critically analyzes a scientific article, chooses news and prepares projects, makes presentations of the obtained results.

    Teaching Process Characteristics:

    To obtain the academic degree of Master of Pharmacy Management, a student needs to accumulate 120 ECTS, which includes the main subjects of the program - 108 ECTS including - master's thesis - 30 ECTS and elective subjects - 12 ECTS, which the student chooses from 54 ECTS of the electives.

    Program Core

    Code Subject ECTS Semester
    ECON5110Managerial Economics6 1
    PHAR5110Pharmacoeconomics and Policy (PEP)6 1
    PHAR5120Pharmaceutical Quality System (PQS)part I6 1
    PHMA5110Public Health and Health care Policy6 1
    PHMA5210Health Management6 1
    PHAR5210Pharmacy management, leadership, marketing and finance12 2
    PHAR5220Pharmaceutical Quality System (PQS)part I I6 2
    PHAR5230Drugs authorization -modern standards6 2
    PHAR5240Business administration of clinical research6 2
    PHAR5250Pharmacovigilance6 2
    PHAR6110Drugs-ethics and practice6 3
    STAT5111Business Statistics6 3
    PHAR6210Master’s Thesis in Pharmacy30 4

    Credits sum:


    Program Elective

    Code Subject ECTS
    ACCT5110Financial Accounting6
    FINA5210Insurance and Risk Management6
    HELM6110Healthcare Organizational Leadership6
    LAWP5250Legal Forms of Administrative Organs Activity6
    MGMT6120International Business6
    MKTG6130Brand Management6
    PHAR6120pharmaceutical management and quality system's practice6
    PHMA5220Health Economics and Insurance6
    PHMA5240Epidemiological and Socio-statistical Research Methods6

    Credits sum:


    Matrix Of Privequisites

    Evaluation system

    Weekly review

    24 point / 24%;

    Research Paper

    16 point/ 16%;

    Midterm exams

    25 point / 25%;

    Final exam

    35 point / 35%

    Point GPA The university assessment   The general assessment in Georgia
    97-100 4,00 A+ A Excellent
    94-96 3,75 A
    91-93 3,50 A-
    87-90 3,25 B+   Very good
    84-86 3,00 B B
    81-83 2,75 B-  
    77-80 2,50 C+   C good
    74-76 2,25 C
    71-73 2,00 C-
    67-70 1,75 D+   D Satisfactory
    64-66 1,50 D
    61-63 1,25 D-
    51-60 1,00 E E Sufficient
    Not passed
    41-50   FX FX Insufficient
    <40   F F Failed

    All Rights Reserved. Copyright © 2020 The University of Georgia